|
1
|
Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study.
|
Gastroenterology
|
2010
|
7.86
|
|
2
|
Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C.
|
J Hepatol
|
2009
|
3.28
|
|
3
|
Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication.
|
Eur J Immunol
|
2008
|
1.70
|
|
4
|
Diffuse esophageal spasm.
|
Am J Gastroenterol
|
2007
|
1.38
|
|
5
|
Functional outcome after perineal stapled prolapse resection for external rectal prolapse.
|
BMC Surg
|
2010
|
0.95
|
|
6
|
Epinephrine versus epinephrine plus fibrin glue injection in peptic ulcer bleeding: a prospective randomized trial.
|
Gastrointest Endosc
|
2002
|
0.91
|
|
7
|
Relevance of incidental colorectal FDG-PET/CT-enhanced lesions.
|
Onkologie
|
2013
|
0.89
|
|
8
|
Interferon and amantadine in naive chronic hepatitis C: a double-blind, randomized, placebo-controlled trial.
|
Hepatology
|
2002
|
0.84
|
|
9
|
Perception of gastrointestinal endoscopy by patients and examiners with and without background music.
|
Digestion
|
2003
|
0.83
|
|
10
|
Malignant biliary stenosis: conventional cytology versus DNA image cytometry.
|
Surg Endosc
|
2010
|
0.81
|
|
11
|
Treatment of hepatitis C in HCV mono-infected and in HIV-HCV co-infected patients: an open-labelled comparison study.
|
Swiss Med Wkly
|
2010
|
0.79
|
|
12
|
Altered esophageal motility and gastroesophageal barrier in patients with jejunal interposition after distal esophageal resection for early stage adenocarcinoma.
|
J Gastrointest Surg
|
2007
|
0.78
|
|
13
|
Benefit of baseline cytometry for surveillance of patients with Barrett's esophagus.
|
Surg Endosc
|
2009
|
0.78
|
|
14
|
Is a barium swallow complementary to endoscopy essential in the preoperative assessment of laparoscopic antireflux and hiatal hernia surgery?
|
Surg Endosc
|
2007
|
0.77
|
|
15
|
The influence of postural changes on gastroesophageal reflux and barrier pressure in nonfasting individuals.
|
Anesth Analg
|
2005
|
0.77
|
|
16
|
Laparoscopic Mesh-augmented Hiatoplasty With Cardiophrenicopexy Versus Laparoscopic Nissen Fundoplication for the Treatment of Gastroesophageal Reflux Disease: A Double-center Randomized Controlled Trial.
|
Ann Surg
|
2015
|
0.77
|
|
17
|
Efficacy of laparoscopic mesh-augmented hiatoplasty in GERD and symptomatic hiatal hernia. Study using combined impedance-pH monitoring.
|
J Gastrointest Surg
|
2008
|
0.76
|
|
18
|
Twenty-four vs. forty-eight weeks of re-therapy with interferon alpha 2b and ribavirin in interferon alpha monotherapy relapsers with chronic hepatitis C.
|
Swiss Med Wkly
|
2003
|
0.76
|
|
19
|
Preoperative administration of esomeprazole has no influence on frequency of refluxes.
|
J Clin Anesth
|
2008
|
0.76
|
|
20
|
Laparoscopic mesh-augmented hiatoplasty as a treatment of gastroesophageal reflux disease and hiatal hernias-preliminary clinical and functional results of a prospective case series.
|
Am J Surg
|
2008
|
0.76
|
|
21
|
Increased detection rates of Barrett's oesophagus without rise in incidence of oesophageal adenocarcinoma.
|
Swiss Med Wkly
|
2003
|
0.75
|
|
22
|
Individualised PPI prescription in patients on combination antiplatelet therapy and upper gastrointestinal events after percutaneous coronary intervention: a cohort study.
|
Wien Med Wochenschr
|
2012
|
0.75
|
|
23
|
Optimizing ribavirin exposure by therapeutic drug monitoring improves treatment response in patients with chronic hepatitis C genotype 1.
|
Am J Gastroenterol
|
2013
|
0.75
|
|
24
|
Long-Term Effiicacy and Safety of Certolizumab Pegol in an Unselected Crohn's Disease Population: The FACTS III Survey.
|
Dig Dis
|
2017
|
0.75
|